Science, ISSN 0036-8075, 11/2009, Volume 326, Issue 5954, pp. 818 - 823
X-linked adrenoleukodystrophy (ALD) is a severe brain demyelinating disease in boys that is caused by a deficiency in ALD protein, an adenosine...
Myeloid cells | Genetic vectors | Demyelinating diseases | B lymphocytes | Stem cells | Hematocrit | Cell lines | Gene therapy | Cells | Hematopoietic stem cells | Research Article | HIV VECTORS | SEVERE COMBINED IMMUNODEFICIENCY | INTEGRATION SITE SELECTION | MICROGLIA | BONE-MARROW-TRANSPLANTATION | HUMAN CD34(+) CELLS | MULTIDISCIPLINARY SCIENCES | MOUSE MODEL | NOD/SCID MICE | LONG-TERM ENGRAFTMENT | DIFFERENTIATE | Myeloablative Agonists - therapeutic use | Genetic Therapy | Leukocytes, Mononuclear - metabolism | Microglia - metabolism | Humans | Adrenoleukodystrophy - pathology | Male | Transplantation, Autologous | ATP-Binding Cassette Transporters - genetics | Hematopoiesis | Adrenoleukodystrophy - therapy | Hematopoietic Stem Cells - physiology | Female | Cell Differentiation | Fatty Acids - blood | Hematopoietic Stem Cells - virology | Child | Microglia - cytology | Gene Expression | Transduction, Genetic | Hematopoietic Stem Cell Transplantation | ATP Binding Cassette Transporter, Sub-Family D, Member 1 | HIV-1 - genetics | Virus Integration | Disease Progression | Cell Lineage | Animals | Brain - pathology | Mice | Adrenoleukodystrophy - genetics | Transplantation Conditioning | Genetic Vectors | Usage | Care and treatment | Adrenoleukodystrophy | Patient outcomes | Transplantation | Health aspects | Viruses | Genetic disorders | Neurological disorders | ABCD1 protein | Life Sciences | Cellular Biology
Myeloid cells | Genetic vectors | Demyelinating diseases | B lymphocytes | Stem cells | Hematocrit | Cell lines | Gene therapy | Cells | Hematopoietic stem cells | Research Article | HIV VECTORS | SEVERE COMBINED IMMUNODEFICIENCY | INTEGRATION SITE SELECTION | MICROGLIA | BONE-MARROW-TRANSPLANTATION | HUMAN CD34(+) CELLS | MULTIDISCIPLINARY SCIENCES | MOUSE MODEL | NOD/SCID MICE | LONG-TERM ENGRAFTMENT | DIFFERENTIATE | Myeloablative Agonists - therapeutic use | Genetic Therapy | Leukocytes, Mononuclear - metabolism | Microglia - metabolism | Humans | Adrenoleukodystrophy - pathology | Male | Transplantation, Autologous | ATP-Binding Cassette Transporters - genetics | Hematopoiesis | Adrenoleukodystrophy - therapy | Hematopoietic Stem Cells - physiology | Female | Cell Differentiation | Fatty Acids - blood | Hematopoietic Stem Cells - virology | Child | Microglia - cytology | Gene Expression | Transduction, Genetic | Hematopoietic Stem Cell Transplantation | ATP Binding Cassette Transporter, Sub-Family D, Member 1 | HIV-1 - genetics | Virus Integration | Disease Progression | Cell Lineage | Animals | Brain - pathology | Mice | Adrenoleukodystrophy - genetics | Transplantation Conditioning | Genetic Vectors | Usage | Care and treatment | Adrenoleukodystrophy | Patient outcomes | Transplantation | Health aspects | Viruses | Genetic disorders | Neurological disorders | ABCD1 protein | Life Sciences | Cellular Biology
Journal Article
Nature genetics, ISSN 1061-4036, 2013, Volume 45, Issue 8, pp. 927 - 932
Pilocytic astrocytoma, the most common childhood brain tumor, is typically associated with mitogen-activated protein kinase (MAPK) pathway alterations....
SIGNAL-TRANSDUCTION | MUTATIONAL PROCESSES | MAPK PATHWAY ACTIVATION | GROWTH | GENES | GENETICS & HEREDITY | DISTINCT SUBGROUPS | HISTONE H3.3 | PAIRED-END | CANCER | NOONAN-SYNDROME | Chromosome Breakpoints | Humans | Receptor, Fibroblast Growth Factor, Type 1 - metabolism | Receptor, trkB - genetics | Receptor, Fibroblast Growth Factor, Type 1 - genetics | Brain Neoplasms - metabolism | MAP Kinase Signaling System | Fibroblast Growth Factors - metabolism | Oncogene Proteins, Fusion - chemistry | Cell Transformation, Neoplastic - genetics | Base Sequence | Proto-Oncogene Proteins B-raf - chemistry | Astrocytoma - genetics | Astrocytoma - metabolism | Cell Line | Brain Neoplasms - genetics | Models, Molecular | Chromosomes, Human, Pair 9 | Chromosomes, Human, Pair 6 | Cell Transformation, Neoplastic - metabolism | Animals | Oncogene Proteins, Fusion - genetics | Proto-Oncogene Proteins B-raf - genetics | Protein Conformation | Mice | Mutation | Receptor, trkB - metabolism | Nervous system cancer | Physiological aspects | Development and progression | Genetic aspects | Research | Protein kinases | Fibroblast growth factor receptors | Medical research | Pediatrics | Brain research | Brain cancer | Genomes | Kinases | Tumors | Cancer
SIGNAL-TRANSDUCTION | MUTATIONAL PROCESSES | MAPK PATHWAY ACTIVATION | GROWTH | GENES | GENETICS & HEREDITY | DISTINCT SUBGROUPS | HISTONE H3.3 | PAIRED-END | CANCER | NOONAN-SYNDROME | Chromosome Breakpoints | Humans | Receptor, Fibroblast Growth Factor, Type 1 - metabolism | Receptor, trkB - genetics | Receptor, Fibroblast Growth Factor, Type 1 - genetics | Brain Neoplasms - metabolism | MAP Kinase Signaling System | Fibroblast Growth Factors - metabolism | Oncogene Proteins, Fusion - chemistry | Cell Transformation, Neoplastic - genetics | Base Sequence | Proto-Oncogene Proteins B-raf - chemistry | Astrocytoma - genetics | Astrocytoma - metabolism | Cell Line | Brain Neoplasms - genetics | Models, Molecular | Chromosomes, Human, Pair 9 | Chromosomes, Human, Pair 6 | Cell Transformation, Neoplastic - metabolism | Animals | Oncogene Proteins, Fusion - genetics | Proto-Oncogene Proteins B-raf - genetics | Protein Conformation | Mice | Mutation | Receptor, trkB - metabolism | Nervous system cancer | Physiological aspects | Development and progression | Genetic aspects | Research | Protein kinases | Fibroblast growth factor receptors | Medical research | Pediatrics | Brain research | Brain cancer | Genomes | Kinases | Tumors | Cancer
Journal Article
Nature Biotechnology, ISSN 1087-0156, 09/2011, Volume 29, Issue 9, pp. 816 - 823
Zinc-finger nucleases (ZFNs) allow gene editing in live cells by inducing a targeted DNA double-strand break (DSB) at a specific genomic locus. However,...
VECTOR INTEGRATION | DNA CLEAVAGE | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | GENE MODIFICATION | IN-VIVO | SITES | DOUBLE-STRAND BREAKS | RESTRICTION ENZYMES | KNOCKOUT | MAMMALIAN-CELLS | LENTIVIRAL VECTORS | Gene Targeting | Humans | Substrate Specificity | Genetic Loci | HIV Integrase - metabolism | DNA Breaks, Double-Stranded | Sequence Analysis, DNA | Genetic Vectors - genetics | Endodeoxyribonucleases - genetics | HIV Integrase - genetics | Endodeoxyribonucleases - metabolism | Cell Line, Tumor | Protein Binding | Lentivirus - genetics | Zinc Fingers - genetics | Binding Sites | Cluster Analysis | Physiological aspects | Nucleases | Zinc finger proteins | Research | DNA binding proteins | Analysis | Genomes | Zinc | Deoxyribonucleic acid--DNA
VECTOR INTEGRATION | DNA CLEAVAGE | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | GENE MODIFICATION | IN-VIVO | SITES | DOUBLE-STRAND BREAKS | RESTRICTION ENZYMES | KNOCKOUT | MAMMALIAN-CELLS | LENTIVIRAL VECTORS | Gene Targeting | Humans | Substrate Specificity | Genetic Loci | HIV Integrase - metabolism | DNA Breaks, Double-Stranded | Sequence Analysis, DNA | Genetic Vectors - genetics | Endodeoxyribonucleases - genetics | HIV Integrase - genetics | Endodeoxyribonucleases - metabolism | Cell Line, Tumor | Protein Binding | Lentivirus - genetics | Zinc Fingers - genetics | Binding Sites | Cluster Analysis | Physiological aspects | Nucleases | Zinc finger proteins | Research | DNA binding proteins | Analysis | Genomes | Zinc | Deoxyribonucleic acid--DNA
Journal Article
Nature, ISSN 0028-0836, 2014, Volume 510, Issue 7506, pp. 537 - 541
Epigenetic alterations, that is, disruption of DNA methylation and chromatin architecture, are now acknowledged as a universal feature of tumorigenesis....
METHYLOME | SUPPRESSOR | HYPERMETHYLATION | GENE | CPG ISLAND SHORES | MULTIDISCIPLINARY SCIENCES | EMBRYONIC STEM-CELLS | CANCER GENOME | DIFFERENTIATION | IDENTIFICATION | EXPRESSION | Chromatin - metabolism | RNA-Binding Proteins - genetics | Humans | Gene Expression Regulation, Neoplastic | Gene Silencing | Genome - genetics | DNA Methylation - genetics | Promoter Regions, Genetic - genetics | Transcription Factors - metabolism | Animals | Chromatin Immunoprecipitation | Medulloblastoma - pathology | Cell Line, Tumor | Female | Transcription, Genetic | Mice | Histones - metabolism | Medulloblastoma - genetics | Binding Sites | Chromatin - genetics | Sequence Analysis, DNA - methods | Analysis | Medulloblastoma | Nucleotide sequencing | Research | Methylation | Health aspects | DNA sequencing | Transcription factors | DNA methylation | Cell division | Epigenetics | Genomes | Gene expression | Deoxyribonucleic acid--DNA | Methods | Tumors
METHYLOME | SUPPRESSOR | HYPERMETHYLATION | GENE | CPG ISLAND SHORES | MULTIDISCIPLINARY SCIENCES | EMBRYONIC STEM-CELLS | CANCER GENOME | DIFFERENTIATION | IDENTIFICATION | EXPRESSION | Chromatin - metabolism | RNA-Binding Proteins - genetics | Humans | Gene Expression Regulation, Neoplastic | Gene Silencing | Genome - genetics | DNA Methylation - genetics | Promoter Regions, Genetic - genetics | Transcription Factors - metabolism | Animals | Chromatin Immunoprecipitation | Medulloblastoma - pathology | Cell Line, Tumor | Female | Transcription, Genetic | Mice | Histones - metabolism | Medulloblastoma - genetics | Binding Sites | Chromatin - genetics | Sequence Analysis, DNA - methods | Analysis | Medulloblastoma | Nucleotide sequencing | Research | Methylation | Health aspects | DNA sequencing | Transcription factors | DNA methylation | Cell division | Epigenetics | Genomes | Gene expression | Deoxyribonucleic acid--DNA | Methods | Tumors
Journal Article
Nature, ISSN 0028-0836, 2014, Volume 511, Issue 7510, pp. 428 - 434
Medulloblastoma is a highly malignant paediatric brain tumour currently treated with a combination of surgery, radiation and chemotherapy, posing a...
PIM-1 | SUPER-ENHANCERS | GENE | FINGER PROTEIN GFI-1 | MYC | MULTIDISCIPLINARY SCIENCES | CELL IDENTITY | MUTATIONS | MODEL | SUBGROUP | GENOME | Proto-Oncogene Proteins - metabolism | Oncogenes - genetics | Humans | Repressor Proteins - genetics | Proto-Oncogene Proteins - genetics | Transcription Factors - genetics | DNA-Binding Proteins - genetics | DNA-Binding Proteins - metabolism | Transcription Factors - metabolism | Chromosomes, Human, Pair 9 - genetics | Animals | Medulloblastoma - pathology | Genomic Structural Variation - genetics | Enhancer Elements, Genetic - genetics | Mice | Medulloblastoma - genetics | Child | Medulloblastoma - classification | Repressor Proteins - metabolism | Medulloblastoma | Analysis | Research | Nucleotide sequencing | Growth factor receptors | Health aspects | DNA sequencing | Medical research | DNA methylation | Epigenetics | Genomes | Gene expression | Deoxyribonucleic acid--DNA | Cancer | Index Medicus | Clinical Medicine | Neurologi | Neurology | Medical and Health Sciences | Medicin och hälsovetenskap | Surgery | Klinisk medicin | Kirurgi
PIM-1 | SUPER-ENHANCERS | GENE | FINGER PROTEIN GFI-1 | MYC | MULTIDISCIPLINARY SCIENCES | CELL IDENTITY | MUTATIONS | MODEL | SUBGROUP | GENOME | Proto-Oncogene Proteins - metabolism | Oncogenes - genetics | Humans | Repressor Proteins - genetics | Proto-Oncogene Proteins - genetics | Transcription Factors - genetics | DNA-Binding Proteins - genetics | DNA-Binding Proteins - metabolism | Transcription Factors - metabolism | Chromosomes, Human, Pair 9 - genetics | Animals | Medulloblastoma - pathology | Genomic Structural Variation - genetics | Enhancer Elements, Genetic - genetics | Mice | Medulloblastoma - genetics | Child | Medulloblastoma - classification | Repressor Proteins - metabolism | Medulloblastoma | Analysis | Research | Nucleotide sequencing | Growth factor receptors | Health aspects | DNA sequencing | Medical research | DNA methylation | Epigenetics | Genomes | Gene expression | Deoxyribonucleic acid--DNA | Cancer | Index Medicus | Clinical Medicine | Neurologi | Neurology | Medical and Health Sciences | Medicin och hälsovetenskap | Surgery | Klinisk medicin | Kirurgi
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 04/2009, Volume 119, Issue 4, pp. 964 - 975
gamma-Retroviral vectors (gamma RVs), which are commonly used in gene therapy, can trigger oncogenesis by insertional mutagenesis. Here, we have dissected the...
MEDICINE, RESEARCH & EXPERIMENTAL | RELATIVE QUANTIFICATION | CANCER GENES | TUMOR SUPPRESSION | HEMATOPOIETIC STEM-CELLS | LENTIVIRAL VECTOR | IN-VIVO | INSERTIONAL MUTAGENESIS | ZINC-FINGER NUCLEASES | MURINE RETROVIRUS | VIRUS VECTORS | Cyclin-Dependent Kinase Inhibitor p16 - deficiency | Cyclin-Dependent Kinase Inhibitor p16 - genetics | Genetic Vectors - adverse effects | Mice, Transgenic | DNA Primers - genetics | Genes, p16 | Mice, Knockout | Animals | Gammaretrovirus - genetics | Base Sequence | Gammaretrovirus - pathogenicity | Hematopoietic Stem Cell Transplantation - adverse effects | Neoplasms, Experimental - genetics | Lentivirus - genetics | Lentivirus - pathogenicity | Mice | Mutation | Neoplasms, Experimental - etiology | Terminal Repeat Sequences | Genetic Therapy - adverse effects | Genetic Therapy - methods | Usage | Retroviruses | Animal models in research | Genetic vectors | Models | Genetic aspects | Research | Gene therapy | Health aspects | Index Medicus | Abridged Index Medicus
MEDICINE, RESEARCH & EXPERIMENTAL | RELATIVE QUANTIFICATION | CANCER GENES | TUMOR SUPPRESSION | HEMATOPOIETIC STEM-CELLS | LENTIVIRAL VECTOR | IN-VIVO | INSERTIONAL MUTAGENESIS | ZINC-FINGER NUCLEASES | MURINE RETROVIRUS | VIRUS VECTORS | Cyclin-Dependent Kinase Inhibitor p16 - deficiency | Cyclin-Dependent Kinase Inhibitor p16 - genetics | Genetic Vectors - adverse effects | Mice, Transgenic | DNA Primers - genetics | Genes, p16 | Mice, Knockout | Animals | Gammaretrovirus - genetics | Base Sequence | Gammaretrovirus - pathogenicity | Hematopoietic Stem Cell Transplantation - adverse effects | Neoplasms, Experimental - genetics | Lentivirus - genetics | Lentivirus - pathogenicity | Mice | Mutation | Neoplasms, Experimental - etiology | Terminal Repeat Sequences | Genetic Therapy - adverse effects | Genetic Therapy - methods | Usage | Retroviruses | Animal models in research | Genetic vectors | Models | Genetic aspects | Research | Gene therapy | Health aspects | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 09/2008, Volume 118, Issue 9, pp. 3143 - 3150
X-linked SCID (SCID-X1) is amenable to correction by gene therapy using conventional gammaretroviral vectors. Here, we describe the occurrence of clonal T cell...
HEMATOPOIETIC-CELLS | MEDICINE, RESEARCH & EXPERIMENTAL | SEVERE COMBINED IMMUNODEFICIENCY | VECTOR INTEGRATION | NOTCH1 | ACUTE LYMPHOBLASTIC-LEUKEMIA | T-CELL DEVELOPMENT | EXPRESSION | RECONSTITUTION | ADA | GAMMA-CHAIN | Follow-Up Studies | LIM Domain Proteins | Humans | Cyclin-Dependent Kinase Inhibitor p16 - genetics | Severe Combined Immunodeficiency - therapy | Infant | Male | DNA-Binding Proteins - genetics | Chromosomes, Human, X | Receptors, Interleukin-2 - genetics | Severe Combined Immunodeficiency - complications | Adaptor Proteins, Signal Transducing | Mutagenesis | Models, Biological | Metalloproteins - genetics | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - etiology | Antineoplastic Agents - pharmacology | Proto-Oncogene Proteins | Mutation | Receptor, Notch1 - genetics | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - therapy | Genetic Therapy - adverse effects | Genetic Therapy - methods | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - complications | Complications and side effects | Care and treatment | Severe combined immunodeficiency | Genetic aspects | Research | Gene therapy | Methods | Risk factors | Index Medicus | Abridged Index Medicus
HEMATOPOIETIC-CELLS | MEDICINE, RESEARCH & EXPERIMENTAL | SEVERE COMBINED IMMUNODEFICIENCY | VECTOR INTEGRATION | NOTCH1 | ACUTE LYMPHOBLASTIC-LEUKEMIA | T-CELL DEVELOPMENT | EXPRESSION | RECONSTITUTION | ADA | GAMMA-CHAIN | Follow-Up Studies | LIM Domain Proteins | Humans | Cyclin-Dependent Kinase Inhibitor p16 - genetics | Severe Combined Immunodeficiency - therapy | Infant | Male | DNA-Binding Proteins - genetics | Chromosomes, Human, X | Receptors, Interleukin-2 - genetics | Severe Combined Immunodeficiency - complications | Adaptor Proteins, Signal Transducing | Mutagenesis | Models, Biological | Metalloproteins - genetics | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - etiology | Antineoplastic Agents - pharmacology | Proto-Oncogene Proteins | Mutation | Receptor, Notch1 - genetics | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - therapy | Genetic Therapy - adverse effects | Genetic Therapy - methods | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - complications | Complications and side effects | Care and treatment | Severe combined immunodeficiency | Genetic aspects | Research | Gene therapy | Methods | Risk factors | Index Medicus | Abridged Index Medicus
Journal Article
The Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 10/2014, Volume 69, Issue 10, p. 2809
 The rapid early-phase decay of plasma HIV-1 RNA during integrase inhibitor-based therapy is not fully understood. The accumulation of biologically active...
Antiretroviral drugs | Human immunodeficiency virus--HIV | Ribonucleic acid--RNA | Drug therapy | Deoxyribonucleic acid--DNA
Antiretroviral drugs | Human immunodeficiency virus--HIV | Ribonucleic acid--RNA | Drug therapy | Deoxyribonucleic acid--DNA
Journal Article
Nature Methods, ISSN 1548-7091, 12/2007, Volume 4, Issue 12, pp. 1051 - 1057
Integrating vector systems used in clinical gene therapy have proven their therapeutic potential in the long-term correction of immunodeficiencies(1-4). The...
SEVERE COMBINED IMMUNODEFICIENCY | GENE-THERAPY | VECTOR INTEGRATION | SCID-X1 | DISEASE | BIOCHEMICAL RESEARCH METHODS | Sequence Alignment - methods | Base Sequence | Chromosome Mapping - methods | Genetic Markers - genetics | DNA Transposable Elements - genetics | Molecular Sequence Data | Sequence Analysis, DNA - methods | Polymerase Chain Reaction - methods | Polymerase chain reaction | Physiological aspects | Usage | Research | Nucleotide sequence | Methods | Biomedical research | Gene therapy | Molecular biology | Research methodology | Genomics
SEVERE COMBINED IMMUNODEFICIENCY | GENE-THERAPY | VECTOR INTEGRATION | SCID-X1 | DISEASE | BIOCHEMICAL RESEARCH METHODS | Sequence Alignment - methods | Base Sequence | Chromosome Mapping - methods | Genetic Markers - genetics | DNA Transposable Elements - genetics | Molecular Sequence Data | Sequence Analysis, DNA - methods | Polymerase Chain Reaction - methods | Polymerase chain reaction | Physiological aspects | Usage | Research | Nucleotide sequence | Methods | Biomedical research | Gene therapy | Molecular biology | Research methodology | Genomics
Journal Article
Nature Biotechnology, ISSN 1087-0156, 06/2006, Volume 24, Issue 6, pp. 687 - 696
Insertional mutagenesis represents a major hurdle to gene therapy and necessitates sensitive preclinical genotoxicity assays. Cdkn2a(-/-) mice are susceptible...
ACTIVATION | HUMAN GENOME | THERAPY | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | TRANSDUCTION | INSERTIONAL MUTAGENESIS | IDENTIFICATION | ACTIVE GENES | CANCER | EXPRESSION | TRANSPLANTATION | Gene Transfer Techniques | Hematopoietic Stem Cells - metabolism | Mutagenicity Tests - methods | Virus Integration | Genetic Vectors - genetics | Neoplasms - virology | Neoplasms - therapy | Animals | Transfection - methods | Neoplasms - genetics | Cell Line, Tumor | Female | Lentivirus - genetics | Mice | Disease Models, Animal | Genetic Therapy - methods | Models | Gene therapy | Toxicity | Rodents | Stem cells | Tumors
ACTIVATION | HUMAN GENOME | THERAPY | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | TRANSDUCTION | INSERTIONAL MUTAGENESIS | IDENTIFICATION | ACTIVE GENES | CANCER | EXPRESSION | TRANSPLANTATION | Gene Transfer Techniques | Hematopoietic Stem Cells - metabolism | Mutagenicity Tests - methods | Virus Integration | Genetic Vectors - genetics | Neoplasms - virology | Neoplasms - therapy | Animals | Transfection - methods | Neoplasms - genetics | Cell Line, Tumor | Female | Lentivirus - genetics | Mice | Disease Models, Animal | Genetic Therapy - methods | Models | Gene therapy | Toxicity | Rodents | Stem cells | Tumors
Journal Article
11.
Full Text
Uncovering and Dissecting the Genotoxicity of Self-inactivating Lentiviral Vectors In Vivo
Molecular Therapy, ISSN 1525-0016, 04/2014, Volume 22, Issue 4, pp. 774 - 785
Self-inactivating (SIN) lentiviral vectors (LV) have an excellent therapeutic potential as demonstrated in preclinical studies and clinical trials. However,...
RNA-POLYMERASE-II | MEDICINE, RESEARCH & EXPERIMENTAL | ACTIVATION | MUTAGENESIS | PROTEIN-KINASE | PTEN | RETROVIRAL VECTORS | LIVER-CANCER | INTEGRATION | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | MOUSE MODEL | GENETICS & HEREDITY | GENE-THERAPY | Genetic Therapy | Promoter Regions, Genetic | Humans | Carcinogenesi
RNA-POLYMERASE-II | MEDICINE, RESEARCH & EXPERIMENTAL | ACTIVATION | MUTAGENESIS | PROTEIN-KINASE | PTEN | RETROVIRAL VECTORS | LIVER-CANCER | INTEGRATION | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | MOUSE MODEL | GENETICS & HEREDITY | GENE-THERAPY | Genetic Therapy | Promoter Regions, Genetic | Humans | Carcinogenesi